News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all News
Venture Capital
Adlyfe is a company that is developing screening and diagnostic products based upon its misfolded-protein detection (MPD) platform. The Company is developing its MPD Platform technology to produce simple, highly sensitive, low-cost and rapid-action test kits for the blood screening, human diagnostics and animal testing markets. The Company is currently working on the following programs: TSE-Pronucleon, to enable rapid and accurate testing of human blood units for vCJD and AD-Pronucleon an MPD Platform-based assay for early diagnosis of Alzheimer’s disease (AD).
Website: http://www.adlyfe.com/